COX-2 and VEGF-C in Gastric Cancer
Author Information
Author(s): Gou Hong-Feng, Chen Xin-Chuan, Zhu Jiang, Jiang Ming, Yang Yu, Cao Dan, Hou Mei
Primary Institution: West China Hospital, Sichuan University, PR China
Hypothesis
The study aims to test the expression of COX-2 and VEGF-C in human gastric cancer and analyze their correlation with lymphatic vessel density, clinicopathologic features, and survival prognosis.
Conclusion
COX-2 expression was associated with survival time, but it was not correlated with VEGF-C or lymphatic vessel density.
Supporting Evidence
- COX-2 expression was found in 69.64% of gastric carcinoma cases.
- VEGF-C expression was found in 55.36% of gastric carcinoma cases.
- Peritumoral lymphatic vessel density was significantly higher than in normal and intratumoral tissue.
- Higher COX-2 expression correlated with poorer survival outcomes.
- Age, COX-2 expression, and peritumoral lymphatic vessel density were independent prognostic factors.
Takeaway
This study looked at how two proteins, COX-2 and VEGF-C, relate to cancer in the stomach and found that while COX-2 might affect how long patients live, it doesn't seem to help in forming new lymphatic vessels.
Methodology
Immunohistochemistry was used to analyze COX-2, VEGF-C, and lymphatic vessel density in gastric adenocarcinomas.
Limitations
The study's findings may be influenced by the small sample size and retrospective nature.
Participant Demographics
56 patients (35 males and 21 females) with a mean age of 56.2 years.
Statistical Information
P-Value
P = 0.003 for lymph node metastasis correlation; P = 0.05 for invasion depth correlation.
Confidence Interval
95% confidence interval for age: 1.228-6.805; for COX-2: 1.192-8.828; for LVD: 1.778-10.360.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website